Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcomeAndrea Rinaldi, Francesco Bertoni, Silvia Govi et al.|Blood|2010Cited by 189
Genomic lesions associated with a different clinical outcome in diffuse large B‐Cell lymphoma treated with R‐CHOP‐21Marta Scandurra, Francesco Bertoni, Michael Mian et al.|British Journal of Haematology|2010Cited by 52
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionMichael Mian, Francesco Bertoni, Marta Scandurra et al.|Annals of Oncology|2011Cited by 22
Array-CGH Identifies Both Common and Subtype-Specific Genomic Aberrations in Marginal Zone LymphomasAndrea Rinaldi, Francesco Bertoni, Paola M. V. Rancoita et al.|Blood|2008Cited by 5
Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.Marta Scandurra, Francesco Bertoni, Michael Mian et al.|Blood|2009Cited by 0